CSF OF NEUROLEPTIC-NAIVE FIRST-EPISODE SCHIZOPHRENIC-PATIENTS - LEVELS OF BIOGENIC-AMINES, SUBSTANCE-P, AND PEPTIDES DERIVED FROM CHROMOGRANIN-A (GE-25) AND SECRETOGRANIN-II (SECRETONEURIN)
C. Miller et al., CSF OF NEUROLEPTIC-NAIVE FIRST-EPISODE SCHIZOPHRENIC-PATIENTS - LEVELS OF BIOGENIC-AMINES, SUBSTANCE-P, AND PEPTIDES DERIVED FROM CHROMOGRANIN-A (GE-25) AND SECRETOGRANIN-II (SECRETONEURIN), Biological psychiatry, 39(11), 1996, pp. 911-918
Lumbar cerebrospinal fluid (CSF) was collected from controls and neuro
leptic-naive patients with their first acute schizophrenic episode. Th
e CSF was analyzed for several biogenic amines and their metabolites [
dopamine, dihydroxyphenylacetic acid (DOPAC), noradrenaline, 5-hydroxy
tryptamine (5-HT) 5-hydroxyindolacetic acid (5-HIAA)]. For these trans
mitters, which are stored and secreted from synaptic vesicles, there w
as no significant difference between controls and schizophrenic patien
ts. As constituents of large dense-core vesicles substance P (SP) and
GE-25 (derived from chromogranin A)-and secretoneurin (derived from se
cretogranin II)-immunoreactivities were determined SP-like immunoreact
ivity levels did not differ between controls and patients; however, GE
-25 was elevated and especially the GE-25/secretoneurin ratio was sign
ificantly (p < .001) higher in patients. Characterization of the immun
oreactivities by high-performance liquid chromatography did not reveal
any difference between patients (n = 3) and controls in the processin
g of the two proproteins chromogranin A and secretogranin II. These da
ta indicate that proteolytic processing of the two widespread constitu
ents of large dense-core vesicles, i.e., chromogranin A and secretogra
nin II, is not altered in schizophrenic patients. The increase in the
chromogranin A / secretoneurin ratio in schizophrenic patients deserve
s further investigation in order to elucidate its possible pathogeneti
c significance.